Aplagon Announces EUR 5 Million Financing to Broaden Phase 2 Trials of its APAC Therapy in Thrombo-Inflammatory Diseases
REYKJAVIK, ICELAND (June 16, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechn…
júní 2026) - Alvotech (NASDAQ: ALVO, ALVO SDB) kynnti í dag ákvörðun um verð og úthlutun í áður boðuðu sölutryggðu hlut…
The Nasdaq-listed kefir pioneer uses experiential retail to drive category awareness as fermented dairy's probiotic cre…
How Dignitas Pokémon UNITE utilized advanced cognitive support to dominate the NAIC and redefine wellness in esports.
MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differen…
-- Setmelanotide therapy achieved robust, sustained and clinically significant weight loss in patients with acquired HO…
REYKJAVIK, ICELAND (June 15, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechn…
júní 2026) - Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að félagið efni til sölutryggðs hlutafjárútboðs í Bandar…
Early mechanistic data positions ETHY-001 as a differentiated candidate in thyroid-eye disease, a space drawing growing…
Functional News covers ingredients, formulations, clinical evidence, and market trends in functional foods and nutraceu…
As the cognitive-wellness category accelerates, operators are eyeing whole-food ingredients with established safety pro…
